2 June 07 -  Derek Denny-Brown - the midbrain and the conscious state
Yesterday, June 1, was the birthday of Derek Denny-Brown, in 1901.  He died in April
1981.  His paper, The midbrain and motor integration. (Proc R Soc Med. 1962 Jul;55:
527-38) was a very exciting discovery for me, on the importance of subcortical
centers of the brain for attention, awareness, and the conscious state.  One of his
last papers on this subject is:


In progress...  More later
blog index
/\
3-4 June 07 - Favorite book: White, Handler & Smith's Principles of Biochemistry
My old textbook of biochemistry is well worn, often consulted, reread, passages
highlighted, and marginal notes continually added.  I have included their comment on
the Bohr Effect of hemoglobin elsewhere on this website.  As one of my son's has
commented, the eyes glaze over whenever I begin to explain the great significance of
the Bohr Effect for why the inferior colliculus (IC) is not usually part of the brain
damage caused by hypoxia -- see
http://www.conradsimon.org/Hemoglobin.shtml

Ralf was seven when I started graduate courses at Boston University.  He was in
school at the old Ward Six at the Massachusetts Mental Health Center in Boston,
where reading books was his favorite activity.  He became most curious about the
books I was reading, especially my biochemistry book, because it had over a
thousand pages!  We used to sit together on the couch watching TV, but I was more
often than not reading, highlighting, and making marginal notes in my textbooks.  Ralf
became interested in the pictures of molecular structures, graphs, and diagrams of
chemical reaction sequences.  One day I went to lookup something in the index, and
found that Ralf had written chapter headings on pages of the index -- starting with
chapter 51 (following chapter 50, the last chapter on lipid-soluble vitamins).

So now whenever I go to the index to find some topic of interest, I am most moved by
the memory of this period of Ralf's childhood.  He was so bright, and interested in
everything around him.  He still is, and I still hope we can channel his energies into
doing more with his life than sitting on the porch of the group home.
blog index
/\
Sweet memories -- my favorite
pages of my favorite book.
How the Bohr Effect usually protects the highly active inferior colliculi (IC) -
7June 07 - June 2007 Scientific American, anesthesia, network signals, & more
From Prague, after a mostly sleepless overnight flight - In the airport before leaving
Boston, I bought the most recent issue of Scientific American, and so far have found
three articles of special interest.  The first (of greatest interest for me) on anesthesia, by
Beverley A. Orser, focuses on neurotransmitter mechanisms.  For me this is an example
of looking at a sub-microscopic level before fully exploring the big picture, the brain
centers most likely involved in loss of consciousness produced by anesthesia.

In the spirit of using radioactive tracers to measure blood flow, Roth and Barlow (1961)
used radioactive labelled anesthetics.  I don't have the paper right in front of me (being
away on vacation), but I believe it was thiopental that distributed in the same pattern as
blood flow.  Barbiturates distributed in a different pattern -- I just had a look, and was
able to download Roth and Barlow's paper from JSTOR.  This is another important
report of research that appears to have been totally forgotten and ignored.  They
emphasize the importance of looking for affinity of drugs in specific anatomical loci.

I will lookup more papers by Orser.  Her research has been on GABA
neurotransmission, and she has chosen to focus on the hippocampus, with some
interesting findings on several different receptor types, and inhibition of
neurotransmission via actions in the vicinity of, but not always directly on neurons.

I will return to this at some point, as well as to network signal transmission, and metabolic
origins of life.  Right now we have to get ready to go to a reception with our tour group.

Roth LJ, Barlow CE (1961) Drugs in the brain. Science 134:22-31.
blog index
/\
22 June 07 - Back to reality, employment worries, and focus on autism
blog index
/\
23 June 07 -  Autism conference in Oslo, 31 Aug - 2 Sep 2007
blog index
/\
25 June 07 -  Dr. Michael Sheff, dental care for people with disabilities
blog index
/\
26-29 June 2007 -  Kernicterus, old and new ideas
Bilirubin is considered to be directly toxic to the brain.  However, bilirubin staining is
not uniform throughout the brain.  Subcortical nuclei that control limb and eye
movements, and nuclei in the auditory pathway are most prominently affected.  The
resulting neurological condition is kernicterus.

Could autism be a variant of kernicterus?

In their first publication on brain damage in the monkey by asphyxia neonatorum,
Rank and Windle made the comment:
    "The human neuropathologic entity most closely resembling the effects of
    asphyxia neonatorum in the monkey is kernicterus," [25, p153].

Lucey et al. determined that bilirubin staining in the brain was found only in infant
monkeys subjected to asphyxia, and that the nuclei affected by bilirubin were exactly
the same ones damaged by asphyxia [22].  The article by Lucey et al. somehow
missed being cited in PubMed, and the only fairly recent citation to it is in the article
by Wennberg [6].  Wennberg points out:
    "Disruption or partial disruption of the blood–brain barrier by disease or
    hypoxic ischemic injury will facilitate transport of bilirubin/albumin into
    brain..." [7, p97]

Zimmerman and Yannet in 1933 summarized a large number of case reports and
concluded that kernicterus was caused by bilirubin staining of subcortical nuclei
already injured by sepsis or oxygen deprivation. They further commented,
    "This differs in no way from the well known fact that any intravital dye will
    localize in zones of injury and will leave unstained tissues which are not
    damaged," [27, p757].

Kernicterus is best known as the result of erythroblastosis fetalis (or Hemolytic
disease of the newborn).
See:
http://www.nlm.nih.gov/medlineplus/ency/article/001298.htm, and note that now
the most common form of maternal-infant incompatibility is ABO incompatibility.

Until recently kernicterus was best known as a condition affecting babies born to Rh-
negative mothers.  After the birth of her first child, placental blood may leak into the
mother's bloodstream, and the Rh-negative mother then produces antibodies to this
factor if the baby is Rh-positive.  In subsequent births maternal antibodies can leak
into the baby's blood stream and destroy the baby's red blood cells with resulting
high levels of bilirubin.  A much heralded treatment for this was devised in the 1960s
[15], the now well-known RhoGAM injection given to Rh negative mothers; this
replaced the earlier and riskier total replacement of affected infants' blood [8].

A placental barrier prevents mixing of maternal and infant blood throughout
pregnancy.  Why this barrier should ever break down during birth of the baby merits
fuller investigation.  The human invention of clamping the umbilical cord at birth
increases blood pressure in the placenta causing small hemorrhages in the placenta
that allow passage of the infant's blood into the mothers circulation with subsequent
formation of maternal antibodies that can likewise leak across the placenta in
subsequent pregnancies [20].

Many women have questions and concerns about modern management of childbirth.  
What we need are more scientific investigations of nature's methods and their
evolution in preservation of our species [4].

References (most recent to oldest):
  1. Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol.
    2003 Nov;29(5):410-21.
  2. Hansen TW. Mechanisms of bilirubin toxicity: clinical implications. Clin
    Perinatol. 2002 Dec;29(4):765-78,
  3. Hansen TW. Bilirubin brain toxicity. J Perinatol. 2001 Dec;21 Suppl 1:S48-51
  4. Wickham, Sara (2002) Anti-D in midwifery : panacea or paradox? LC call no.
    RG629.E78 W53 2001
  5. Hansen TW. Kernicterus in term and near-term infants--the specter walks
    again. Acta Paediatr. 2000 Oct;89(10):1155-7.
  6. Hansen TW. Pioneers in the scientific study of neonatal jaundice and
    kernicterus. Pediatrics. 2000 Aug;106(2):E15.
  7. Wennberg RP (2000) The blood-brain barrier and bilirubin encephalopathy.
    Cell Mol Neurobiol. 2000 Feb;20(1):97-109.
  8. Pearson HA. (1998) Commentary: Replacement transfusion as a treatment of
    erythroblastosis fetalis, by Louis K. Diamond, MD, Pediatrics, 1948;2:520-524.
    Pediatrics. 102 (supplement):203-5.
  9. Valaes T, Koliopoulos C, Koltsidopoulos A. The impact of phototherapy in the
    management of neonatal hyperbilirubinemia: comparison of historical cohorts.
    Acta Paediatr. 1996 Mar;85(3):273-6.
  10. Worley G, Erwin CW, Goldstein RF, Provenzale JM, Ware RE (1996) Delayed
    development of sensorineural hearing loss after neonatal hyperbilirubinemia: a
    case report with brain magnetic resonance imaging. Developmental Medicine
    and Child Neurology 38:271-277.
  11. Roger C, Koziel V, Vert P, Nehlig A (1996) Autoradiographic mapping of local
    cerebral permeability to bilirubin in immature rats: effects of hyperbilirubinemia.
    Pediatric Research 39:64-71.
  12. Roger C, Koziel V, Vert P, Nehlig A (1995) Regional cerebral metabolic
    consequences of bilirubin in rat depend upon post-gestational age at the time
    of hyperbilirubinemia. Brain Research. Developmental Brain Research 87:194-
    202.
  13. Ebbesen F, Knudsen A. The possible risk of bilirubin encephalopathy as
    predicted by plasma parameters in neonates with previous severe asphyxia.
    Eur J Pediatr. 1992  Dec;151(12):910-2.
  14. Valaes T. Bilirubin toxicity: the problem was solved a generation ago.
    Pediatrics. 1992 May;89(5 Pt 1):819-21.
  15. Mittendorf R, Williams MA (1991). Rho(D) immunoglobulin (RhoGAM): how it
    came into being. Obstetrics and Gynecology. 77:301-3.
  16. Connolly AM, Volpe JJ. Clinical features of bilirubin encephalopathy. Clin
    Perinatol. 1990 Jun;17(2):371-9.
  17. Valaes T, Gellis SS. Is kernicterus always the definitive evidence of bilirubin
    toxicity? Pediatrics. 1981 Jun;67(6):940-1.
  18. Doshi N, Klionsky B, Fujikura T, MacDonald H. Pulmonary yellow hyaline
    membranes in neonates. Hum Pathol. 1980 Sep;11(5 Suppl):520-7.
  19. Saigal S, O'Neill A, Surainder Y, Chua LB, Usher R. Placental transfusion and
    hyperbilirubinemia in the premature. Pediatrics. 1972 Mar;49(3):406-19.
  20. Dunn PM. The placental venous pressure during and after the third stage of
    labour following early cord ligation. J Obstet Gynaecol Br Commonw. 1966 Oct;
    73(5):747-56.
  21. Chen H (1964) Kernicterus in the Chinese newborn. A morphological and
    spectrophotometric study.  Journal of Neuropathology and Experimental
    Neurology 23:527-549.
  22. Lucey JF, Hibbard E, Behrman RE, Esquival FO, Windle WF (1964)
    Kernicterus in asphyxiated newborn monkeys.  Experimental Neurology 9:43-
    58.
  23. Rozdilsky B and Olszewski J (1961). Experimental study of the toxicity of
    bilirubin in newborn animals. Journal of Neuropathology and Experimental
    Neurology, 20, 193-205.
  24. Margoles C, Katami K, Moloney Wc, Pentschew A, Sutow Ww, Haymaker W.
    Kernicterus in Japanese infants. II. Pathologic data in 25 cases of kernicterus
    and in 20 cases of systemic icterus without kernicterus.World Neurol. 1960
    Sep;1:254-71.
  25. Ranck JB Jr, Windle WF. Brain damage in the monkey, macaca mulatta, by
    asphyxia neonatorum. Exp Neurol. 1959 Jun;1(2):130-54.
  26. Gerrard J. Kernicterus.  Brain. 1952 Dec;75(4):526-70.
  27. Zimmerman HM and Yannet H (1933). Kernicterus: jaundice of the nuclear
    masses of the brain.  American Journal of Diseases of Children, 45, 740-759.
  28. Schmörl G (1904) Zur Kenntnis des Ikterus neonatorum, insbesondere der
    dabie auftretenden Gehirn veränderungen.  Verhandlung der deutschen
    pathologischen Gesellschaft 6:109-115.
  29. Orth J (1875) Ueber das Vorkommen von Bilirubinkrystallen bei neugebornen
    Kindern.  Archiv für pathologische Anatomie und Physiologie und für klinische
    Medicin 63:447-462

e-Letters I have written:
http://pediatrics.aappublications.org/cgi/eletters/114/1/229
In response to an article by Blackmon et al. on prevention of bilirubin-induced brain
injury in newborn infants.

http://fn.bmj.com/cgi/eletters/89/2/F101
In response to an article by Murray & Roberts on risks of blood transfusions for
newborn infants.  The standard practice of clamping the umbilical cord, to prevent
hyperbilirubinemia, then often creates a subsequent need for transfusion.

http://neoreviews.aappublications.org/cgi/eletters/5/4/e142
In response to an article by Philip & Saigal recommending "wait a minute" before
clamping the umbilical cord.  Saigal was one of the authors of a paper reporting
placental transfusion as cause of hyperbilirubinemia in premature infants [16].

Google:bilirubin levels in newborns
http://www.labtestsonline.org/understanding/analytes/bilirubin/test.html
    It is not uncommon to see high bilirubin levels in newborns, typically 1 to 3
    days old. This is sometimes called physiologic jaundice of the newborn.
    Within the first 24 hours of life, up to 50% of full-term newborns, and an
    even greater percentage of pre-term babies, may have a high bilirubin
    level. This is because at birth, the newborn’s liver is not fully mature and
    lacks the ability to process bilirubin as well as normal. This situation usually
    resolves itself within a few days. In other instances, newborns’ red blood
    cells (RBCs) may have been destroyed because of blood incompatibilities
    between the baby and its mother, called hemolytic disease of the newborn.

http://www.kidshealth.org/parent/pregnancy_newborn/common/jaundice.html
Updated and reviewed by: Steven Dowshen, MD
Date reviewed: April 2005

http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5023a4.htm

Google: kernicterus bilirubin
http://www.neuropathologyweb.org/chapter3/chapter3dBilirubinencephalopathy.html

Google: kernicterus symptoms
http://www.emedicine.com/ped/topic1247.htm
blog index
/\
30 June 07 -  Milieu research, and privatization turmoil
I Worked in the intensive treatment unit today, my last day working for UMass Medical
School.  Tomorrow, my employer will be Mental Health Management (MHM)
Correctional Services Inc.  Today was pretty quiet, until just before change of shift,
which often happens.  First I got a phone call from a tearful mom.  I took her number,
per protocol, to give to the psychiatrist to call her back.  The psychiatrist walked in
the door just then, and picked up the phone, but the connection was lost.  At that
point three blasts from the warning horn went off, and an emergency was announced
on one of the maximum security units, "Two inmates fighting."

I quickly fetched two admission packets, and a few minutes later the first combatant
was brought in, screaming and yelling unmentionable obscenities.  He was far too
agitated for me to try to interview him, so he was taken to a holding cell where he
continued to yell and rattle the bars of the door.

A few minutes later, the second sullen and sheepish looking inmate was brought in.  I
interviewed him, but had difficulty understanding anything he said, in part because of
the banging and screaming from the holding cell across the hall.  Finally, in broken
English, the quiet inmate told me, "I gave him my two hamburgers at lunch."  After
considerable questioning I pieced together the story.  The outraged inmate across
the hall had requested the two pieces of chicken that would be served for dinner
tonight.

"I told him I promised my chicken to another guy."

The patient I could interview then told me he is vegetarian, and always gives away his
meat to other people.  I hope they will now insist that he go through the special diet
line in the chow hall, and be given vegetarian meals.

The din from across the corridor finally diminished to a whine, and only occasional
banging of the door.  I was allowed to try to interview him, and got quite a different
nonsensical story about foul remarks and foul activities.  When I asked about the
extra chicken he might have gotten for supper, he suddenly got loud and unruly
again.

"I need to see the doctor.  I need to get my medications changed," he yelled.

The psychiatrist interviewed both inmates.  The vegetarian was allowed to return to
his unit, and the loudly upset man was admitted to ITU.  I had to write a report on
each patient.  Meanwhile, my relief for second shift arrived, and took over getting
afternoon meds ready.  While I was sitting at the computer, the tearful mom called
back.  I gave her the information I had been given when I thought my son, Ralf, was
the victim in a newspaper report of a man drowned in Boston Harbor.

"Your son is in a safe place.  He is getting good care."

She thanked me, and told me she is leaving this evening to visit family in Portugal.  
She explained that she will lose the money she spent on the tickets if she doesn't go,
and that her son knows about this trip, and that she will be back in two weeks.  She
has sent a money order to the hospital so that her son will be able to purchase soda
and toiletries etc. from the canteen.  I assured her that we will take good care of her
son, and that he will probably have a phone account setup by the time she returns so
that she can talk with him.  He is a new admission, and beginning to calm down and
become adjusted.  Better that he is with us than out tramping around on the streets.

I finished my reports, then left with paperwork for unit mailboxes in the supervisors'
office.  There was a gathering of people saying goodbye.  They will not be working
for the new vendor.  I am sure that some of them will return again at some point to
work at Bridgewater State Hospital.  It is certainly the most interesting place I have
worked in my long career.

I started working at Bridgewater nearly 16 years ago, when the Republican Governor,
William Weld, privatized health services in Massachusetts prisons.  This will be the
fourth vendor I have worked for, and my feeling about privatization is that it just
creates turmoil whenever the vendor changes.

Prisons are an essential function of government, and medical care is an essential
obligation that prisons have to inmates -- This has not always been the case, in the
Middle Ages, or in the days of Herman Melville (as described in his story, Bartleby the
Scrivener).  But improved standards for prisons is one example of how civilization has
moved forward and gotten better.  I think that health and mental health care in the
prisons should be paid for directly, without a private mediator, but apparently MHM
has a good track record in many other states, so maybe they will continue as a long-
term contractor.  I want to at least give it a try.
blog index
/\